These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 1504008)

  • 1. Novel antiprogestins Org 31806 and 31710: interaction with mammalian progesterone receptor and DNA binding of antisteroid receptor complexes.
    Mizutani T; Bhakta A; Kloosterboer HJ; Moudgil VK
    J Steroid Biochem Mol Biol; 1992 Aug; 42(7):695-704. PubMed ID: 1504008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of R5020 and RU486 binding to progesterone receptor from calf uterus.
    Hurd C; Moudgil VK
    Biochemistry; 1988 May; 27(10):3618-23. PubMed ID: 3408715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mammalian progesterone receptor shows differential sensitivity to sulfhydryl group modifying agents when bound to agonist and antagonist ligands.
    Moudgil VK; Anter MJ; Hurd C
    J Biol Chem; 1989 Feb; 264(4):2203-11. PubMed ID: 2914901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ZK98299, a novel antiprogesterone that does not interact with chicken oviduct progesterone receptor.
    Moudgil VK; Nath R; Bhakta A; Nakao M
    Biochim Biophys Acta; 1991 Sep; 1094(2):185-92. PubMed ID: 1892900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transformation of human progesterone receptor in the presence of the progestin (R5020) and the antiprogestin (RU486).
    Miller MM; Hurd C; Moudgil VK
    J Steroid Biochem; 1988 Nov; 31(5):777-83. PubMed ID: 3199817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoanalysis of calf uterine progesterone receptor: modulation of receptor-associated 90 kDa heat-shock protein. f.
    Hurd C; Nakao M; Eliezer N; Moudgil VK
    Mol Cell Biochem; 1991 Jun; 105(1):73-83. PubMed ID: 1922009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transformation of calf uterine progesterone receptor: analysis of the process when receptor is bound to progesterone and RU38486.
    Moudgil VK; Hurd C
    Biochemistry; 1987 Aug; 26(16):4993-5001. PubMed ID: 3663641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The antiprogesterone RU486 stabilizes the heterooligomeric, non-DNA-binding, 8S-form of the rabbit uterus cytosol progesterone receptor.
    Renoir JM; Radanyi C; Baulieu EE
    Steroids; 1989; 53(1-2):1-20. PubMed ID: 2772964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ZK98299--a new antiprogesterone: biochemical characterization of steroid binding parameters in the calf uterine cytosol.
    Nath R; Bhakta A; Moudgil VK
    Arch Biochem Biophys; 1992 Jan; 292(1):303-10. PubMed ID: 1727646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of cycloalkanoprogesterones with mammalian progesterone receptor: binding of pregna-D'-pentaranes in the calf uterine cytosol.
    Bhakta A; Herman M; Levina IS; Moudgil VK
    Mol Cell Biochem; 1993 Aug; 125(2):153-61. PubMed ID: 8283970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of ligand binding, DNA binding and phosphorylation of progesterone receptor by two novel progesterone receptor antagonist ligands.
    Hurd C; Underwood B; Herman M; Iwasaki K; Kloosterboer HJ; Dinda S; Moudgil VK
    Mol Cell Biochem; 1997 Oct; 175(1-2):205-12. PubMed ID: 9350053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for separate binding sites for progesterone and RU486 in the chick oviduct.
    Moudgil VK; Lombardo G; Hurd C; Eliezer N; Agarwal MK
    Biochim Biophys Acta; 1986 Nov; 889(2):192-9. PubMed ID: 3778947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the steroid antagonist RU486 on dimerization of the human progesterone receptor.
    DeMarzo AM; Oñate SA; Nordeen SK; Edwards DP
    Biochemistry; 1992 Nov; 31(43):10491-501. PubMed ID: 1420166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ionic and ligand-specific effects on the DNA binding of progesterone receptor bound to the synthetic progestin R5020 and the antiprogestin RU486.
    Chao CC; Thomas TJ; Ebede P; Gallo MA; Thomas T
    Cancer Res; 1991 Aug; 51(15):3938-45. PubMed ID: 1855211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The antiprogestin RU38 486: receptor-mediated progestin versus antiprogestin actions screened in estrogen-insensitive T47Dco human breast cancer cells.
    Horwitz KB
    Endocrinology; 1985 Jun; 116(6):2236-45. PubMed ID: 4039656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RU486, a progestin antagonist, binds to progesterone receptors in a human endometrial cancer cell line and reverses the growth inhibition by progestins.
    Terakawa N; Shimizu I; Tanizawa O; Matsumoto K
    J Steroid Biochem; 1988 Aug; 31(2):161-6. PubMed ID: 2457133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of immunosuppressants FK506 and rapamycin on the heterooligomeric form of the progesterone receptor.
    Renoir JM; Le Bihan S; Mercier-Bodard C; Gold A; Arjomandi M; Radanyi C; Baulieu EE
    J Steroid Biochem Mol Biol; 1994 Jan; 48(1):101-10. PubMed ID: 7510997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of antiestrogen versus antiprogestin on transformed and nontransformed steroid receptors.
    Turner JW; Ruh MF; Ward DT; Ruh TS
    J Steroid Biochem Mol Biol; 1991 Feb; 38(2):197-203. PubMed ID: 2004041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of progesterone receptor binding in the ovine uterus.
    Bauer MA; Gorell TA
    Steroids; 1980 Nov; 36(5):581-91. PubMed ID: 7192894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progestin and antiprogestin effects on progesterone receptor transformation.
    Spilman CH; Gibson RE; Beuving DC; Campbell JA
    J Steroid Biochem; 1986 Jan; 24(1):383-9. PubMed ID: 2939296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.